sample group age gender stage OS OS.time DSS DSS.time DFI DFI.time PFI PFI.time EZH2 TP53 TCGA-2V-A95S tumor NA MALE Stage II 0 NA 0 NA 0 NA 0 NA 9.4807 10.118 TCGA-2Y-A9GS tumor 58 MALE 1 724 1 724 1 102 1 102 8.9203 10.2014 TCGA-2Y-A9GT tumor 51 MALE Stage I 1 1624 1 1624 1 1083 1 1083 8.0081 9.0499 TCGA-2Y-A9GU tumor 55 FEMALE Stage I 0 1939 0 1939 0 1939 0 1939 8.3973 9.192 TCGA-2Y-A9GV tumor 54 FEMALE Stage I 1 2532 1 2532 0 2532 1 1745 6.594 8.5603 TCGA-2Y-A9GW tumor 64 MALE Stage I 1 1271 1 1271 1 1229 1 1229 7.9302 10.5193 TCGA-2Y-A9GX tumor 68 MALE Stage I 0 2442 0 2442 NA NA 1 2133 7.5285 9.773 TCGA-2Y-A9GY tumor 64 FEMALE Stage II 1 757 1 757 1 637 1 637 8.4232 10.2175 TCGA-2Y-A9GZ tumor 82 FEMALE Stage II 1 848 1 848 1 719 1 719 7.496 9.3016 TCGA-2Y-A9H0 tumor 49 MALE Stage III 0 3675 0 3675 0 3675 0 3675 9.5576 9.3685 TCGA-2Y-A9H1 tumor 58 MALE Stage I 1 1229 1 1229 1 321 1 321 6.229 9.9046 TCGA-2Y-A9H2 tumor 64 FEMALE Stage I 0 1731 0 1731 0 1731 0 1731 8.4337 10.9918 TCGA-2Y-A9H3 tumor 45 MALE Stage II 0 1516 0 1516 1 22 1 22 7.7189 9.9832 TCGA-2Y-A9H4 tumor 68 MALE Stage I 0 1452 0 1452 0 1452 0 1452 8.511 7.7992 TCGA-2Y-A9H5 tumor 59 FEMALE Stage I 1 555 1 555 1 258 1 258 8.0157 10.2432 TCGA-2Y-A9H6 tumor 68 FEMALE Stage I 0 357 0 357 0 357 0 357 7.223 10.6821 TCGA-2Y-A9H7 tumor 81 FEMALE Stage I 0 1168 0 1168 1 1117 1 1117 8.0845 10.6096 TCGA-2Y-A9H8 tumor 85 FEMALE 1 633 1 633 1 398 1 398 8.8722 10.5455 TCGA-2Y-A9H9 tumor 70 MALE Stage I 0 697 0 697 1 59 1 59 8.5581 8.3294 TCGA-2Y-A9HA tumor 70 MALE Stage II 1 36 1 36 NA NA 1 36 7.8887 7.1135 TCGA-2Y-A9HB tumor 66 MALE Stage I 0 260 0 260 0 260 0 260 7.4393 9.5537 TCGA-3K-AAZ8 tumor 65 MALE Stage III 0 396 0 396 NA NA 1 151 7.011 10.4305 TCGA-4R-AA8I tumor 66 MALE Stage II 1 262 1 262 1 158 1 158 7.9989 8.8957 TCGA-5C-A9VG tumor 58 MALE Stage II 0 328 0 328 0 328 0 328 8.9527 10.4378 TCGA-5C-A9VH tumor 70 MALE Stage I 0 322 0 322 0 322 0 322 8.0591 10.5273 TCGA-5C-AAPD tumor 61 MALE Stage II 0 20 0 20 0 20 0 20 9.8751 9.0849 TCGA-5R-AA1C tumor 57 MALE Stage II 0 520 0 520 0 520 0 520 6.9155 9.8963 TCGA-5R-AA1D tumor 17 FEMALE Stage III 0 449 0 449 0 449 0 449 6.355 10.3659 TCGA-5R-AAAM tumor 65 FEMALE Stage II 1 46 0 46 0 46 0 46 6.1654 8.6622 TCGA-BC-4072 tumor 74 FEMALE Stage III 1 1490 1 1490 NA NA 1 475 8.1877 9.269 TCGA-BC-4073 tumor 73 MALE Stage III 0 849 0 849 NA NA 0 849 8.4868 9.3797 TCGA-BC-A10Q tumor 72 FEMALE 1 1135 1 1135 NA NA 1 340 8.1774 10.2559 TCGA-BC-A10Q normal 72 FEMALE 1 1135 1 1135 NA NA 1 340 5.678 9.6513 TCGA-BC-A10R tumor 66 FEMALE 1 308 1 308 1 199 1 199 7.3893 8.1692 TCGA-BC-A10R normal 66 FEMALE 1 308 1 308 1 199 1 199 5.7938 9.4026 TCGA-BC-A10S tumor 81 MALE 1 1423 1 1423 1 1130 1 1130 6.2176 10.6554 TCGA-BC-A10T tumor 76 MALE 1 837 1 837 NA NA 1 598 7.1939 9.52 TCGA-BC-A10T normal 76 MALE 1 837 1 837 NA NA 1 598 5.5313 10.1805 TCGA-BC-A10U tumor 69 MALE 1 837 1 837 NA NA 1 586 8.0317 9.7106 TCGA-BC-A10U normal 69 MALE 1 837 1 837 NA NA 1 586 5.2324 9.4636 TCGA-BC-A10W tumor 50 MALE 1 91 1 91 NA NA 1 91 9.4307 10.3106 TCGA-BC-A10W normal 50 MALE 1 91 1 91 NA NA 1 91 5.643 9.4196 TCGA-BC-A10X tumor 52 FEMALE Stage III 1 770 0 770 0 770 0 770 6.0937 10.0389 TCGA-BC-A10X normal 52 FEMALE Stage III 1 770 0 770 0 770 0 770 4.9403 9.5068 TCGA-BC-A10Y tumor 76 MALE 1 711 1 711 1 400 1 400 9.0992 7.198 TCGA-BC-A10Y normal 76 MALE 1 711 1 711 1 400 1 400 4.7099 10.0338 TCGA-BC-A10Z tumor 62 FEMALE Stage I 1 34 0 34 0 34 0 34 8.8 8.5357 TCGA-BC-A10Z normal 62 FEMALE Stage I 1 34 0 34 0 34 0 34 6.059 10.1555 TCGA-BC-A110 tumor 51 FEMALE 1 2116 1 2116 1 2057 1 2057 5.7987 9.4912 TCGA-BC-A110 normal 51 FEMALE 1 2116 1 2116 1 2057 1 2057 5.6855 9.3781 TCGA-BC-A112 tumor 80 MALE 1 153 0 153 0 153 0 153 8.5536 10.4349 TCGA-BC-A216 tumor 62 FEMALE Stage III 0 1351 0 1351 0 1351 0 1351 9.3192 9.569 TCGA-BC-A216 normal 62 FEMALE Stage III 0 1351 0 1351 0 1351 0 1351 6.1904 9.3448 TCGA-BC-A217 tumor 75 FEMALE Stage II 1 1397 0 1397 0 1397 0 1397 8.349 10.1124 TCGA-BC-A3KF tumor 66 FEMALE Stage I 0 8 0 8 0 8 0 8 8.7429 8.6276 TCGA-BC-A3KG tumor 68 FEMALE Stage II 0 680 0 680 1 209 1 209 8.3297 9.5217 TCGA-BC-A5W4 tumor 69 MALE Stage III 1 547 0 547 NA NA 1 384 7.8854 9.1935 TCGA-BC-A69H tumor 64 MALE Stage II 0 444 0 444 0 444 0 444 8.8182 7.3747 TCGA-BC-A69I tumor 69 MALE Stage I 0 387 0 387 0 387 0 387 6.6044 9.6927 TCGA-BC-A8YO tumor 66 FEMALE Stage III 0 562 0 562 1 220 1 220 9.0874 10.59 TCGA-BD-A2L6 tumor 69 MALE 0 1363 0 1363 1 415 1 415 8.4192 8.7705 TCGA-BD-A2L6 normal 69 MALE 0 1363 0 1363 1 415 1 415 6.6239 10.0119 TCGA-BD-A3EP tumor 75 FEMALE Stage I 0 409 0 409 0 409 0 409 7.6802 10.1558 TCGA-BD-A3EP normal 75 FEMALE Stage I 0 409 0 409 0 409 0 409 4.8087 9.6537 TCGA-BD-A3ER tumor 62 MALE Stage II 0 1115 0 1115 1 226 1 226 6.8651 10.5013 TCGA-BW-A5NO tumor 50 MALE Stage III 0 20 0 20 NA NA 0 20 7.7061 9.9676 TCGA-BW-A5NP tumor 26 FEMALE Stage IV 0 0 0 0 NA NA 1 102 8.928 10.6551 TCGA-BW-A5NQ tumor 63 MALE Stage I 0 0 0 0 NA NA 0 0 10.1896 7.3184 TCGA-CC-5258 tumor 48 MALE Stage II 1 129 0 129 NA NA 0 129 9.3299 9.0099 TCGA-CC-5259 tumor 60 FEMALE Stage III 0 250 0 250 1 180 1 180 6.6559 7.3964 TCGA-CC-5260 tumor 61 FEMALE Stage III 1 87 0 87 NA NA 0 87 8.4706 10.9659 TCGA-CC-5261 tumor 44 MALE Stage II 1 97 0 97 NA NA 0 97 8.425 10.4922 TCGA-CC-5262 tumor 67 MALE Stage III 1 103 0 103 NA NA 0 103 8.1009 10.3027 TCGA-CC-5263 tumor 35 MALE Stage III 1 129 0 129 NA NA 0 129 10.0081 7.8609 TCGA-CC-5264 tumor 71 MALE Stage III 1 102 0 102 NA NA 0 102 10.1162 6.5084 TCGA-CC-A123 tumor 24 FEMALE Stage III 0 219 0 219 NA NA 1 145 8.2409 9.8382 TCGA-CC-A1HT tumor 50 MALE Stage III 1 101 0 101 NA NA 0 101 9.3694 10.5598 TCGA-CC-A3M9 tumor 45 MALE Stage III 1 300 1 300 1 219 1 219 9.3878 10.473 TCGA-CC-A3MA tumor 61 MALE Stage III 1 303 1 303 1 261 1 261 9.4445 10.7257 TCGA-CC-A3MB tumor 36 MALE Stage III 1 315 1 315 0 315 1 260 9.2914 9.8598 TCGA-CC-A3MC tumor 54 MALE Stage III 0 363 0 363 1 297 1 297 8.8835 8.987 TCGA-CC-A5UC tumor 63 MALE Stage III 1 347 1 347 0 347 1 312 8.5426 10.0909 TCGA-CC-A5UD tumor 45 MALE Stage III 1 304 1 304 1 182 1 182 8.7504 11.2599 TCGA-CC-A5UE tumor 48 MALE Stage III 1 272 1 272 1 175 1 175 8.8228 9.7419 TCGA-CC-A7IE tumor 57 MALE Stage III 1 217 1 217 0 217 1 169 8.7402 11.3766 TCGA-CC-A7IF tumor 59 MALE Stage III 1 649 1 649 0 649 1 254 9.2127 8.0688 TCGA-CC-A7IG tumor 47 MALE Stage II 1 299 1 299 1 195 1 195 9.2152 7.7229 TCGA-CC-A7IH tumor 58 MALE Stage III 0 365 0 365 0 365 0 365 7.758 9.5783 TCGA-CC-A7II tumor 54 MALE Stage III 0 399 0 399 1 278 1 278 10.2657 10.9257 TCGA-CC-A7IJ tumor 56 MALE Stage II 0 382 0 382 0 382 0 382 9.7965 11.4289 TCGA-CC-A7IK tumor 59 MALE Stage III 1 262 1 262 1 150 1 150 8.5717 7.189 TCGA-CC-A7IL tumor 61 MALE Stage III 1 278 1 278 1 179 1 179 7.5472 8.444 TCGA-CC-A8HS tumor 18 MALE Stage III 1 300 1 300 1 201 1 201 9.7622 9.7821 TCGA-CC-A8HT tumor 74 MALE Stage III 1 140 1 140 1 83 1 83 9.7913 9.6935 TCGA-CC-A8HU tumor 39 FEMALE Stage III 1 344 1 344 1 301 1 301 10.0243 9.3638 TCGA-CC-A8HV tumor 51 FEMALE Stage II 1 279 1 279 1 149 1 149 9.1739 9.8368 TCGA-CC-A9FS tumor 55 MALE Stage II 0 211 0 211 0 211 1 109 8.2749 9.8045 TCGA-CC-A9FU tumor 52 FEMALE Stage III 0 0 0 0 0 0 0 0 9.175 6.9534 TCGA-CC-A9FV tumor 57 MALE Stage III 0 0 0 0 0 0 0 0 5.8253 9.4239 TCGA-CC-A9FW tumor 68 MALE Stage III 0 248 0 248 1 153 1 153 8.2731 10.5821 TCGA-DD-A113 tumor 55 FEMALE Stage II 0 2425 0 2425 1 1676 1 1676 8.8854 10.5645 TCGA-DD-A113 normal 55 FEMALE Stage II 0 2425 0 2425 1 1676 1 1676 4.6733 9.4838 TCGA-DD-A114 tumor 42 MALE Stage II 1 1149 0 1149 0 1149 0 1149 9.7361 10.3659 TCGA-DD-A114 normal 42 MALE Stage II 1 1149 0 1149 0 1149 0 1149 7.2006 10.0427 TCGA-DD-A115 tumor 53 MALE Stage III 1 2542 1 2542 1 469 1 469 8.1293 8.3738 TCGA-DD-A116 tumor 68 MALE Stage III 1 1622 0 1622 1 828 1 828 7.9317 9.6348 TCGA-DD-A116 normal 68 MALE Stage III 1 1622 0 1622 1 828 1 828 5.8319 9.409 TCGA-DD-A118 tumor 77 FEMALE Stage II 0 3437 0 3437 1 658 1 658 7.7025 9.5622 TCGA-DD-A118 normal 77 FEMALE Stage II 0 3437 0 3437 1 658 1 658 4.6906 8.9342 TCGA-DD-A119 tumor 40 MALE Stage IV 1 223 NA 223 NA NA 0 223 6.3401 9.2746 TCGA-DD-A119 normal 40 MALE Stage IV 1 223 NA 223 NA NA 0 223 5.0181 9.5724 TCGA-DD-A11A tumor 67 MALE Stage I 0 79 0 79 0 79 0 79 7.8599 8.5898 TCGA-DD-A11A normal 67 MALE Stage I 0 79 0 79 0 79 0 79 5.4215 9.8423 TCGA-DD-A11B tumor 73 MALE Stage I 1 14 0 14 NA NA 0 14 6.8688 10.2832 TCGA-DD-A11B normal 73 MALE Stage I 1 14 0 14 NA NA 0 14 4.6347 9.5571 TCGA-DD-A11C tumor 69 MALE Stage I 0 662 0 662 NA NA 0 662 7.9106 9.7734 TCGA-DD-A11C normal 69 MALE Stage I 0 662 0 662 NA NA 0 662 5.5497 9.3167 TCGA-DD-A11D tumor 57 FEMALE Stage I 1 1560 1 1560 1 498 1 498 7.1877 8.6214 TCGA-DD-A11D normal 57 FEMALE Stage I 1 1560 1 1560 1 498 1 498 5.982 9.5537 TCGA-DD-A1EA tumor 68 MALE Stage II 0 2415 0 2415 1 754 1 754 7.6929 10.0384 TCGA-DD-A1EB tumor 72 FEMALE Stage I 0 2017 0 2017 1 505 1 505 7.2092 9.1283 TCGA-DD-A1EB normal 72 FEMALE Stage I 0 2017 0 2017 1 505 1 505 4.7765 9.6364 TCGA-DD-A1EC tumor 20 FEMALE Stage I 0 602 0 602 1 299 1 299 8.6257 9.3271 TCGA-DD-A1EC normal 20 FEMALE Stage I 0 602 0 602 1 299 1 299 5.1153 9.6873 TCGA-DD-A1ED tumor 68 MALE Stage I 0 2301 0 2301 0 2301 0 2301 4.7281 9.5407 TCGA-DD-A1EE tumor 73 MALE Stage III 1 349 1 349 1 44 1 44 8.0914 10.5185 TCGA-DD-A1EE normal 73 MALE Stage III 1 349 1 349 1 44 1 44 5.3872 9.7503 TCGA-DD-A1EF tumor 57 FEMALE Stage I 1 394 1 394 NA NA 1 394 8.3278 11.1054 TCGA-DD-A1EG tumor 76 MALE Stage I 1 1372 1 1372 1 875 1 875 7.961 10.276 TCGA-DD-A1EG normal 76 MALE Stage I 1 1372 1 1372 1 875 1 875 4.9954 9.8166 TCGA-DD-A1EH tumor 23 MALE Stage III 0 1495 0 1495 1 120 1 120 8.4615 10.1645 TCGA-DD-A1EH normal 23 MALE Stage III 0 1495 0 1495 1 120 1 120 5.3209 9.9415 TCGA-DD-A1EI tumor 46 MALE Stage I 0 183 0 183 0 183 0 183 8.4014 8.5164 TCGA-DD-A1EI normal 46 MALE Stage I 0 183 0 183 0 183 0 183 6.4159 9.577 TCGA-DD-A1EJ tumor 71 FEMALE Stage III 1 1005 1 1005 1 263 1 263 8.328 10.036 TCGA-DD-A1EJ normal 71 FEMALE Stage III 1 1005 1 1005 1 263 1 263 6.172 9.7126 TCGA-DD-A1EK tumor 64 FEMALE Stage IV 1 558 1 558 NA NA 1 167 6.9737 8.1189 TCGA-DD-A1EL tumor 23 MALE Stage II 1 415 1 415 NA NA 1 415 8.0074 9.5138 TCGA-DD-A1EL normal 23 MALE Stage II 1 415 1 415 NA NA 1 415 6.1634 9.1343 TCGA-DD-A39V tumor 77 MALE Stage II 1 643 1 643 1 455 1 455 7.4839 9.6934 TCGA-DD-A39V normal 77 MALE Stage II 1 643 1 643 1 455 1 455 4.7759 9.4162 TCGA-DD-A39W tumor 29 FEMALE Stage III 1 827 NA 827 0 827 0 827 7.4024 9.7408 TCGA-DD-A39W normal 29 FEMALE Stage III 1 827 NA 827 0 827 0 827 3.3125 9.7235 TCGA-DD-A39X tumor 78 FEMALE Stage I 1 1694 1 1694 1 1032 1 1032 6.549 9.8393 TCGA-DD-A39X normal 78 FEMALE Stage I 1 1694 1 1694 1 1032 1 1032 4.1769 9.8326 TCGA-DD-A39Y tumor 67 MALE Stage I 1 171 0 171 0 171 0 171 9.4338 9.142 TCGA-DD-A39Z tumor 43 FEMALE Stage II 1 601 0 601 0 601 0 601 7.9366 9.8894 TCGA-DD-A39Z normal 43 FEMALE Stage II 1 601 0 601 0 601 0 601 5.2378 9.7296 TCGA-DD-A3A1 tumor 65 MALE Stage III 1 233 0 233 0 233 0 233 7.6604 9.9746 TCGA-DD-A3A1 normal 65 MALE Stage III 1 233 0 233 0 233 0 233 5.3869 9.0585 TCGA-DD-A3A2 tumor 76 FEMALE Stage I 1 2131 0 2131 0 2131 0 2131 6.4956 9.3505 TCGA-DD-A3A2 normal 76 FEMALE Stage I 1 2131 0 2131 0 2131 0 2131 4.3341 9.7013 TCGA-DD-A3A3 tumor 45 MALE Stage I 1 535 NA 535 0 535 0 535 7.0877 8.5444 TCGA-DD-A3A3 normal 45 MALE Stage I 1 535 NA 535 0 535 0 535 5.3561 9.2523 TCGA-DD-A3A4 tumor 37 MALE Stage III 1 612 1 612 1 87 1 87 5.1864 9.2398 TCGA-DD-A3A4 normal 37 MALE Stage III 1 612 1 612 1 87 1 87 5.6335 10.4878 TCGA-DD-A3A5 tumor 66 FEMALE Stage III 1 3125 1 3125 1 84 1 84 8.2507 8.2078 TCGA-DD-A3A5 normal 66 FEMALE Stage III 1 3125 1 3125 1 84 1 84 4.7369 9.3586 TCGA-DD-A3A6 tumor 72 FEMALE Stage II 1 3258 0 3258 0 3258 0 3258 5.4347 10.7696 TCGA-DD-A3A6 normal 72 FEMALE Stage II 1 3258 0 3258 0 3258 0 3258 3.2587 9.6353 TCGA-DD-A3A7 tumor 67 MALE Stage III 1 419 1 419 1 144 1 144 8.0666 6.5932 TCGA-DD-A3A8 tumor 75 MALE Stage II 1 11 0 11 0 11 0 11 6.823 9.1763 TCGA-DD-A3A8 normal 75 MALE Stage II 1 11 0 11 0 11 0 11 3.0771 9.497 TCGA-DD-A3A9 tumor 64 FEMALE Stage IV 1 931 1 931 NA NA 1 289 7.5455 9.3072 TCGA-DD-A4NA tumor 67 FEMALE Stage III 0 1008 0 1008 0 1008 0 1008 8.2326 9.5334 TCGA-DD-A4NB tumor 25 MALE Stage I 0 989 0 989 1 912 1 912 6.3294 9.834 TCGA-DD-A4ND tumor 56 FEMALE Stage I 0 2746 0 2746 0 2746 1 15 7.3251 9.8979 TCGA-DD-A4NE tumor 75 FEMALE Stage III 1 660 1 660 1 190 1 190 9.6914 10.3005 TCGA-DD-A4NF tumor 72 MALE Stage I 0 942 0 942 1 656 1 656 6.3369 9.5859 TCGA-DD-A4NG tumor 77 MALE Stage III 1 802 1 802 1 430 1 430 8.0994 9.861 TCGA-DD-A4NH tumor 65 FEMALE Stage III 0 917 0 917 1 161 1 161 9.2685 9.1545 TCGA-DD-A4NI tumor 67 MALE Stage II 0 816 0 816 0 816 0 816 6.9496 8.9704 TCGA-DD-A4NJ tumor 54 FEMALE Stage II 0 928 0 928 1 549 1 549 9.4994 8.7753 TCGA-DD-A4NK tumor 80 FEMALE Stage III 1 1210 1 1210 1 89 1 89 7.2221 9.546 TCGA-DD-A4NL tumor 46 MALE Stage I 0 1711 0 1711 0 1711 0 1711 4.4873 9.7278 TCGA-DD-A4NN tumor 56 FEMALE Stage I 1 899 1 899 1 166 1 166 9.0968 10.7349 TCGA-DD-A4NO tumor 65 MALE Stage I 0 2245 0 2245 1 990 1 990 6.7311 9.2581 TCGA-DD-A4NP tumor 32 MALE Stage I 0 3308 0 3308 1 1286 1 1286 4.4378 9.6097 TCGA-DD-A4NQ tumor 60 MALE Stage II 1 373 1 373 1 126 1 126 9.244 6.6953 TCGA-DD-A4NR tumor 85 FEMALE Stage I 1 9 0 9 0 9 0 9 8.6938 10.267 TCGA-DD-A4NS tumor 61 FEMALE Stage I 1 2456 1 2456 1 893 1 893 6.5295 10.0391 TCGA-DD-A4NV tumor 61 MALE Stage III 0 2398 0 2398 0 2398 0 2398 7.467 9.3262 TCGA-DD-A73A tumor 71 MALE Stage I 0 728 0 728 0 728 0 728 7.2653 9.7648 TCGA-DD-A73B tumor 72 FEMALE Stage I 1 283 1 283 1 240 1 240 8.9954 8.7162 TCGA-DD-A73C tumor 65 FEMALE Stage III 0 701 0 701 1 566 1 566 7.0171 9.615 TCGA-DD-A73D tumor 68 FEMALE Stage II 0 693 0 693 1 592 1 592 6.4427 9.3069 TCGA-DD-A73E tumor 66 MALE Stage I 0 44 0 44 0 44 0 44 7.659 8.4976 TCGA-DD-A73F tumor 77 FEMALE Stage I 0 1085 0 1085 0 1085 0 1085 8.3152 9.1516 TCGA-DD-A73G tumor 73 FEMALE Stage I 0 3478 0 3478 0 3478 0 3478 7.9005 10.2652 TCGA-DD-AA3A tumor 81 FEMALE Stage I 1 410 0 410 0 410 0 410 8.8661 11.5793 TCGA-DD-AAC8 tumor 72 MALE Stage I 1 16 0 16 0 16 0 16 6.7725 10.4993 TCGA-DD-AAC9 tumor 51 MALE Stage I 0 347 0 347 0 347 0 347 6.4372 9.8656 TCGA-DD-AACA tumor 65 MALE Stage I 0 2301 0 2301 1 776 1 776 8.7159 9.3061 TCGA-DD-AACA tumor 65 MALE Stage I 0 2301 0 2301 1 776 1 776 8.56175 9.62715 TCGA-DD-AACB tumor 74 FEMALE Stage I 0 2324 0 2324 0 2324 0 2324 7.5079 9.2179 TCGA-DD-AACC tumor 61 MALE Stage I 1 1685 1 1685 1 537 1 537 8.4938 9.8941 TCGA-DD-AACD tumor 48 MALE Stage I 1 381 1 381 1 151 1 151 7.7386 10.6835 TCGA-DD-AACE tumor 62 MALE Stage I 0 2184 0 2184 1 1279 1 1279 7.5143 6.6094 TCGA-DD-AACF tumor 68 MALE Stage I 1 365 1 365 1 119 1 119 9.4425 7.3511 TCGA-DD-AACG tumor 52 MALE Stage II 1 469 1 469 1 125 1 125 8.8773 6.9981 TCGA-DD-AACH tumor 69 MALE Stage II 1 195 0 195 1 83 1 83 10.6336 7.0376 TCGA-DD-AACI tumor 69 MALE Stage II 0 1618 0 1618 1 1432 1 1432 7.4624 9.6823 TCGA-DD-AACJ tumor 75 MALE Stage II 0 2102 0 2102 1 100 1 100 6.1024 9.3627 TCGA-DD-AACK tumor 70 MALE Stage I 0 9 0 9 0 9 0 9 7.5027 10.789 TCGA-DD-AACL tumor 66 FEMALE Stage I 1 107 NA 107 0 107 0 107 9.6053 9.8038 TCGA-DD-AACN tumor 32 MALE Stage I 0 1302 0 1302 1 357 1 357 7.2455 10.876 TCGA-DD-AACO tumor 40 MALE Stage I 0 1876 0 1876 1 479 1 479 8.9721 10.0493 TCGA-DD-AACP tumor 64 MALE Stage I 0 415 0 415 0 415 0 415 9.9149 10.8416 TCGA-DD-AACQ tumor 50 MALE Stage II 1 432 1 432 1 105 1 105 8.2737 6.7076 TCGA-DD-AACS tumor 39 MALE Stage I 0 1804 0 1804 0 1804 0 1804 8.8903 10.0044 TCGA-DD-AACT tumor 69 FEMALE Stage I 0 1562 0 1562 0 1562 0 1562 7.2066 9.7624 TCGA-DD-AACU tumor 59 MALE Stage I 0 1567 0 1567 0 1567 0 1567 7.2911 9.9463 TCGA-DD-AACV tumor 53 MALE Stage I 0 1531 0 1531 1 344 1 344 8.7854 6.7316 TCGA-DD-AACW tumor 43 MALE Stage I 0 1424 0 1424 0 1424 0 1424 8.4825 11.3086 TCGA-DD-AACX tumor 66 MALE Stage II 0 170 0 170 1 42 1 42 7.8772 9.0489 TCGA-DD-AACY tumor 61 MALE Stage I 0 1450 0 1450 1 776 1 776 7.0426 10.11 TCGA-DD-AACZ tumor 63 FEMALE Stage I 1 171 0 171 1 88 1 88 8.276 8.2936 TCGA-DD-AAD0 tumor 73 FEMALE Stage I 0 137 0 137 1 47 1 47 8.3238 8.8273 TCGA-DD-AAD1 tumor 51 FEMALE Stage I 0 564 0 564 NA NA 1 127 7.4534 10.0333 TCGA-DD-AAD2 tumor 66 MALE Stage I 0 658 0 658 0 658 0 658 8.0289 10.1883 TCGA-DD-AAD3 tumor 43 MALE Stage I 0 1295 0 1295 0 1295 0 1295 6.7168 9.1752 TCGA-DD-AAD5 tumor 54 MALE Stage I 0 1345 0 1345 1 130 1 130 8.5967 10.5656 TCGA-DD-AAD6 tumor 66 MALE Stage III 0 672 0 672 1 50 1 50 8.3065 9.421 TCGA-DD-AAD8 tumor 73 FEMALE Stage I 0 1219 0 1219 0 1219 0 1219 8.3302 7.2022 TCGA-DD-AADA tumor 66 FEMALE Stage I 0 1233 0 1233 0 1233 0 1233 7.3045 9.905 TCGA-DD-AADB tumor 51 MALE Stage I 0 1242 0 1242 0 1242 0 1242 9.0045 10.5772 TCGA-DD-AADC tumor 53 MALE Stage I 1 425 1 425 1 101 1 101 9.0337 9.8802 TCGA-DD-AADD tumor 51 MALE Stage I 0 1231 0 1231 0 1231 0 1231 8.7903 9.3564 TCGA-DD-AADF tumor 64 FEMALE Stage I 1 115 0 115 0 115 0 115 8.1917 9.4416 TCGA-DD-AADG tumor 70 MALE Stage III 0 1145 0 1145 1 270 1 270 7.6548 8.8197 TCGA-DD-AADI tumor 43 FEMALE Stage I 0 1085 0 1085 0 1085 0 1085 7.9902 11.1075 TCGA-DD-AADJ tumor 70 FEMALE Stage I 0 1066 0 1066 0 1066 0 1066 7.0519 10.4299 TCGA-DD-AADK tumor 68 FEMALE Stage II 0 1049 0 1049 0 1049 0 1049 7.711 10.2313 TCGA-DD-AADL tumor 58 MALE Stage I 0 636 0 636 0 636 0 636 8.9188 8.7984 TCGA-DD-AADM tumor 58 MALE Stage II 1 12 0 12 0 12 0 12 8.571 10.1089 TCGA-DD-AADN tumor 59 MALE Stage I 0 898 0 898 0 898 0 898 8.7115 8.0238 TCGA-DD-AADO tumor 55 MALE Stage I 0 453 0 453 0 453 0 453 7.904 11.2385 TCGA-DD-AADP tumor 45 MALE Stage I 0 458 0 458 0 458 0 458 7.5402 10.255 TCGA-DD-AADQ tumor 59 MALE Stage II 0 436 0 436 0 436 0 436 7.2126 10.3747 TCGA-DD-AADR tumor 58 MALE Stage I 0 2028 0 2028 1 1700 1 1700 7.9654 9.8131 TCGA-DD-AADS tumor 63 MALE Stage I 0 474 0 474 0 474 0 474 6.1332 9.3176 TCGA-DD-AADU tumor 60 MALE Stage II 0 554 0 554 0 554 0 554 5.8483 8.9578 TCGA-DD-AADV tumor 50 MALE Stage I 0 574 0 574 0 574 0 574 8.8114 7.6113 TCGA-DD-AADW tumor 48 MALE Stage I 0 587 0 587 1 386 1 386 9.9667 10.1428 TCGA-DD-AADY tumor 55 FEMALE Stage I 0 555 0 555 0 555 0 555 7.2349 8.8164 TCGA-DD-AAE0 tumor 45 FEMALE Stage III 0 555 0 555 0 555 0 555 8.1912 10.6927 TCGA-DD-AAE1 tumor 52 MALE Stage I 0 552 0 552 0 552 0 552 7.7375 10.2891 TCGA-DD-AAE2 tumor 51 MALE Stage I 0 638 0 638 0 638 0 638 7.5451 8.9055 TCGA-DD-AAE3 tumor 50 MALE Stage I 0 566 0 566 0 566 0 566 5.7209 9.2328 TCGA-DD-AAE4 tumor 49 FEMALE Stage I 0 608 0 608 1 111 1 111 7.4317 9.7784 TCGA-DD-AAE6 tumor 59 FEMALE Stage I 0 141 0 141 1 105 1 105 9.4357 5.9739 TCGA-DD-AAE7 tumor 72 MALE Stage I 0 644 0 644 0 644 0 644 6.5639 9.9248 TCGA-DD-AAE9 tumor 69 MALE Stage I 0 722 0 722 0 722 0 722 7.0733 9.7381 TCGA-DD-AAEA tumor 65 MALE Stage I 0 575 0 575 0 575 0 575 8.722 7.9456 TCGA-DD-AAEB tumor 60 MALE Stage I 0 478 0 478 0 478 0 478 7.0615 8.8549 TCGA-DD-AAED tumor 51 MALE Stage I 0 763 0 763 1 198 1 198 8.4241 9.836 TCGA-DD-AAEE tumor 55 MALE Stage I 0 810 0 810 1 224 1 224 8.1213 7.7006 TCGA-DD-AAEG tumor 59 FEMALE Stage I 0 719 0 719 0 719 0 719 7.6562 8.9425 TCGA-DD-AAEH tumor 73 MALE Stage I 0 784 0 784 1 644 1 644 7.5114 10.0972 TCGA-DD-AAEI tumor 72 MALE Stage I 0 1531 0 1531 1 491 1 491 8.8384 7.5859 TCGA-DD-AAEK tumor 51 MALE Stage II 0 1067 0 1067 0 1067 0 1067 7.9607 9.5669 TCGA-DD-AAVP tumor 48 MALE Stage I 0 2752 0 2752 1 903 1 903 7.0681 8.7447 TCGA-DD-AAVQ tumor 38 MALE Stage I 0 2728 0 2728 1 1509 1 1509 8.6611 10.4129 TCGA-DD-AAVR tumor 44 MALE Stage I 0 2513 0 2513 0 2513 0 2513 7.6618 9.7409 TCGA-DD-AAVS tumor 56 MALE Stage I 0 1823 0 1823 0 1823 0 1823 7.9901 10.7907 TCGA-DD-AAVU tumor 46 MALE Stage II 0 2202 0 2202 1 1630 1 1630 7.6289 9.7829 TCGA-DD-AAVV tumor 56 MALE Stage II 0 2455 0 2455 0 2455 0 2455 8.1697 9.4538 TCGA-DD-AAVW tumor 35 MALE Stage I 0 2317 0 2317 0 2317 0 2317 7.2173 9.6713 TCGA-DD-AAVX tumor 38 MALE Stage II 0 1718 0 1718 1 393 1 393 7.2515 10.4154 TCGA-DD-AAVY tumor 56 MALE Stage III 0 1970 0 1970 0 1970 0 1970 6.4881 10.131 TCGA-DD-AAVZ tumor 38 MALE Stage I 0 1900 0 1900 0 1900 0 1900 7.1126 10.6796 TCGA-DD-AAW0 tumor 54 MALE Stage I 0 2015 0 2015 0 2015 0 2015 7.2814 10.1788 TCGA-DD-AAW1 tumor 55 MALE Stage III 0 1989 0 1989 0 1989 0 1989 6.2468 9.2684 TCGA-DD-AAW2 tumor 69 MALE Stage I 0 1855 0 1855 1 391 1 391 7.9959 10.0072 TCGA-DD-AAW3 tumor 69 MALE Stage I 0 1633 0 1633 0 1633 0 1633 8.0525 9.0836 TCGA-ED-A459 tumor 47 MALE Stage II 0 910 0 910 0 910 0 910 9.2608 9.4572 TCGA-ED-A4XI tumor 58 MALE Stage II 0 819 0 819 0 819 0 819 6.1577 10.12 TCGA-ED-A5KG tumor 60 FEMALE Stage II 0 854 0 854 0 854 1 110 8.6215 10.3775 TCGA-ED-A627 tumor 74 MALE Stage I 0 423 0 423 0 423 0 423 6.8685 10.2238 TCGA-ED-A66X tumor 35 MALE Stage III 0 406 0 406 1 124 1 124 8.4021 10.778 TCGA-ED-A66Y tumor 51 FEMALE Stage III 1 296 0 296 0 296 0 296 10.1699 10.691 TCGA-ED-A7PX tumor 48 FEMALE Stage II 0 6 0 6 0 6 0 6 7.5739 10.3896 TCGA-ED-A7PY tumor 20 FEMALE Stage II 0 390 0 390 0 390 0 390 6.9479 10.5934 TCGA-ED-A7PZ tumor 61 MALE Stage II 0 6 0 6 0 6 0 6 8.2623 6.6529 TCGA-ED-A7XO tumor 29 MALE Stage III 0 427 0 427 1 262 1 262 8.1626 9.3959 TCGA-ED-A7XP tumor 53 FEMALE Stage II 0 400 0 400 1 187 1 187 7.9657 9.455 TCGA-ED-A82E tumor 60 FEMALE Stage III 0 408 0 408 0 408 0 408 6.1422 11.1092 TCGA-ED-A8O5 tumor 59 FEMALE Stage III 0 406 0 406 0 406 0 406 8.3118 11.0031 TCGA-ED-A8O6 tumor 50 FEMALE Stage III 1 56 0 56 0 56 0 56 8.0793 6.5265 TCGA-ED-A97K tumor 54 MALE Stage III 0 6 0 6 0 6 0 6 7.8254 10.4923 TCGA-EP-A12J tumor 62 MALE Stage I 0 570 0 570 0 570 0 570 7.3856 9.9352 TCGA-EP-A12J normal 62 MALE Stage I 0 570 0 570 0 570 0 570 6.0915 9.7611 TCGA-EP-A26S tumor 70 MALE Stage I 0 608 0 608 NA NA 0 608 7.7395 9.9216 TCGA-EP-A26S normal 70 MALE Stage I 0 608 0 608 NA NA 0 608 4.2658 9.4467 TCGA-EP-A2KA tumor 52 FEMALE Stage III 1 627 1 627 1 293 1 293 8.8364 10.38 TCGA-EP-A2KB tumor 46 FEMALE Stage I 1 596 1 596 1 161 1 161 8.0325 11.5359 TCGA-EP-A2KC tumor 62 MALE Stage I 1 19 0 19 0 19 0 19 8.0259 9.2758 TCGA-EP-A3JL tumor 76 MALE Stage I 0 303 0 303 NA NA 0 303 7.7844 10.316 TCGA-EP-A3RK tumor 73 MALE Stage III 0 363 0 363 NA NA 1 320 8.2558 10.3774 TCGA-EP-A3RK normal 73 MALE Stage III 0 363 0 363 NA NA 1 320 5.0264 9.8698 TCGA-ES-A2HS tumor 80 MALE Stage I 1 688 0 688 0 688 0 688 6.9834 8.5706 TCGA-ES-A2HT tumor 54 MALE Stage I 1 438 0 438 0 438 0 438 6.2999 9.2385 TCGA-ES-A2HT normal 54 MALE Stage I 1 438 0 438 0 438 0 438 6.9809 10.0199 TCGA-FV-A23B tumor 70 FEMALE Stage II 1 1852 1 1852 1 1453 1 1453 9.3304 9.8881 TCGA-FV-A23B normal 70 FEMALE Stage II 1 1852 1 1852 1 1453 1 1453 6.145 9.6347 TCGA-FV-A2QQ tumor 80 MALE Stage I 0 729 0 729 0 729 0 729 7.5515 10.3023 TCGA-FV-A2QR tumor 75 MALE Stage I 1 581 1 581 NA NA 1 561 8.6742 8.8871 TCGA-FV-A2QR normal 75 MALE Stage I 1 581 1 581 NA NA 1 561 6.4499 9.8283 TCGA-FV-A3I0 tumor 76 FEMALE Stage II 0 848 0 848 1 159 1 159 7.4153 10.6973 TCGA-FV-A3I0 normal 76 FEMALE Stage II 0 848 0 848 1 159 1 159 5.2455 9.3869 TCGA-FV-A3I1 tumor 81 FEMALE Stage II 1 247 0 247 0 247 0 247 8.6244 9.7102 TCGA-FV-A3I1 normal 81 FEMALE Stage II 1 247 0 247 0 247 0 247 5.0621 9.7733 TCGA-FV-A3R2 tumor 75 MALE Stage I 1 194 0 194 0 194 0 194 8.2451 6.3543 TCGA-FV-A3R2 normal 75 MALE Stage I 1 194 0 194 0 194 0 194 6.1092 9.6298 TCGA-FV-A3R3 tumor 38 FEMALE Stage I 1 366 0 366 0 366 0 366 6.5689 9.8059 TCGA-FV-A495 tumor 51 FEMALE Stage II 0 1 0 1 0 1 0 1 8.5926 9.9058 TCGA-FV-A496 tumor 84 FEMALE Stage I 0 10 0 10 0 10 0 10 6.359 6.6819 TCGA-FV-A4ZP tumor 78 MALE Stage III 1 2486 0 2486 NA NA 0 2486 8.6304 10.2755 TCGA-FV-A4ZQ tumor 52 MALE Stage I 0 12 0 12 0 12 0 12 9.0946 10.9766 TCGA-G3-A25S tumor 64 MALE Stage I 1 416 1 416 NA NA 1 37 7.7141 9.8398 TCGA-G3-A25T tumor 45 FEMALE Stage III 0 1553 0 1553 1 452 1 452 8.7317 10.2791 TCGA-G3-A25U tumor 63 FEMALE Stage I 0 1636 0 1636 0 1636 0 1636 8.774 9.4704 TCGA-G3-A25V tumor 68 MALE Stage I 0 860 0 860 1 489 1 489 7.3422 9.6241 TCGA-G3-A25X tumor 73 MALE Stage II 0 1779 0 1779 0 1779 0 1779 9.4147 8.0146 TCGA-G3-A25Y tumor 52 FEMALE Stage I 1 452 1 452 1 355 1 355 9.3238 10.0091 TCGA-G3-A25Z tumor 58 MALE Stage I 0 655 0 655 0 655 0 655 7.0107 8.545 TCGA-G3-A3CG tumor 80 MALE Stage I 0 673 0 673 NA NA 1 329 7.3606 9.4217 TCGA-G3-A3CH tumor 53 MALE Stage III 0 780 0 780 1 116 1 116 8.5797 9.2485 TCGA-G3-A3CH normal 53 MALE Stage III 0 780 0 780 1 116 1 116 5.2229 9.0602 TCGA-G3-A3CI tumor 71 MALE Stage I 0 180 0 180 0 180 0 180 6.1363 9.4529 TCGA-G3-A3CJ tumor 52 MALE Stage II 0 594 0 594 1 296 1 296 6.2872 9.2692 TCGA-G3-A3CK tumor 61 MALE Stage I 0 585 0 585 0 585 0 585 6.7463 9.6471 TCGA-G3-A5SI tumor 44 MALE Stage II 1 768 1 768 1 348 1 348 9.8954 9.2524 TCGA-G3-A5SJ tumor 59 MALE Stage I 0 698 0 698 1 308 1 308 8.6 9.7419 TCGA-G3-A5SK tumor 58 MALE Stage I 0 744 0 744 1 483 1 483 5.6872 7.9624 TCGA-G3-A5SL tumor 70 MALE Stage II 0 621 0 621 0 621 0 621 7.5501 9.5797 TCGA-G3-A5SM tumor 58 MALE Stage II 0 520 0 520 1 252 1 252 8.0749 8.5655 TCGA-G3-A6UC tumor 65 MALE Stage III 0 671 0 671 1 639 1 639 7.3298 8.9889 TCGA-G3-A7M5 tumor 76 MALE Stage I 0 447 0 447 0 447 0 447 6.9026 9.0244 TCGA-G3-A7M6 tumor 60 FEMALE Stage I 0 632 0 632 1 293 1 293 8.0293 10.096 TCGA-G3-A7M7 tumor 65 MALE Stage I 0 361 0 361 0 361 0 361 6.3205 10.0685 TCGA-G3-A7M8 tumor 31 MALE Stage I 0 430 0 430 NA NA 0 430 6.6117 9.8636 TCGA-G3-A7M9 tumor 70 MALE Stage III 1 56 NA 56 0 56 0 56 9.5112 7.6228 TCGA-G3-AAUZ tumor 48 MALE Stage I 0 480 0 480 0 480 0 480 8.251 8.8315 TCGA-G3-AAV0 tumor 58 MALE Stage I 0 476 0 476 0 476 0 476 6.7051 9.7745 TCGA-G3-AAV1 tumor 51 MALE Stage III 1 359 1 359 1 49 1 49 7.5952 9.2762 TCGA-G3-AAV2 tumor 50 MALE Stage I 0 372 0 372 0 372 0 372 5.9131 9.8016 TCGA-G3-AAV3 tumor 58 FEMALE Stage II 0 412 0 412 0 412 0 412 8.1326 10.3613 TCGA-G3-AAV4 tumor 83 FEMALE Stage I 1 27 0 27 0 27 0 27 7.578 6.9063 TCGA-G3-AAV5 tumor 67 MALE Stage II 0 354 0 354 1 117 1 117 7.8551 9.7739 TCGA-G3-AAV6 tumor 53 FEMALE Stage III 1 65 1 65 1 44 1 44 9.2027 10.2977 TCGA-G3-AAV7 tumor 38 MALE Stage II 0 361 0 361 0 361 0 361 9.8048 8.7614 TCGA-GJ-A3OU tumor 59 MALE Stage I 0 879 0 879 NA NA 1 879 7.6172 10.025 TCGA-GJ-A6C0 tumor 75 FEMALE Stage II 1 31 NA 31 NA NA 0 31 8.4639 9.2552 TCGA-GJ-A9DB tumor 68 MALE Stage I 1 67 NA 67 0 67 0 67 8.0549 8.6457 TCGA-HP-A5MZ tumor 78 MALE Stage I 1 91 0 91 0 91 0 91 6.9222 9.8411 TCGA-HP-A5N0 tumor 90 FEMALE 1 1147 1 1147 1 179 1 179 5.8225 9.1331 TCGA-K7-A5RF tumor 64 MALE Stage I 0 631 0 631 1 205 1 205 6.2788 9.5533 TCGA-K7-A5RG tumor 66 MALE Stage I 0 519 0 519 0 519 0 519 8.8795 8.731 TCGA-K7-A6G5 tumor 66 MALE Stage I 0 512 0 512 NA NA 0 512 6.8888 9.604 TCGA-K7-AAU7 tumor 61 MALE Stage II 0 359 0 359 NA NA 1 58 8.4273 10.023 TCGA-KR-A7K0 tumor 65 MALE Stage I 1 65 0 65 0 65 0 65 7.4154 9.3271 TCGA-KR-A7K2 tumor 64 MALE Stage I 0 829 0 829 0 829 0 829 7.9289 10.2912 TCGA-KR-A7K7 tumor 61 FEMALE Stage II 0 951 0 951 1 239 1 239 8.5586 11.1328 TCGA-KR-A7K8 tumor 57 MALE Stage I 0 906 0 906 0 906 0 906 8.1868 9.6042 TCGA-LG-A6GG tumor 79 FEMALE Stage II 0 387 0 387 0 387 0 387 7.7926 7.8144 TCGA-LG-A9QC tumor 48 MALE Stage I 0 425 0 425 0 425 0 425 6.7087 9.8863 TCGA-LG-A9QD tumor 68 MALE Stage III 0 366 0 366 0 366 0 366 6.4547 9.5412 TCGA-MI-A75C tumor 64 MALE Stage I 0 291 0 291 0 291 0 291 7.1301 10.7079 TCGA-MI-A75E tumor 61 MALE Stage III 0 507 0 507 0 507 0 507 7.7497 9.4563 TCGA-MI-A75G tumor 63 MALE Stage II 0 698 0 698 0 698 0 698 7.1839 9.6195 TCGA-MI-A75H tumor 77 MALE 0 747 0 747 1 301 1 301 6.8155 9.8945 TCGA-MI-A75I tumor 61 MALE 0 630 0 630 1 265 1 265 8.5108 8.6677 TCGA-MR-A520 tumor 58 MALE Stage I 0 229 0 229 NA NA 0 229 5.2851 9.3557 TCGA-MR-A8JO tumor 34 MALE Stage I 0 330 0 330 NA NA 0 330 7.6313 10.2458 TCGA-NI-A4U2 tumor 71 MALE Stage III 1 1791 1 1791 1 106 1 106 6.7727 7.4008 TCGA-NI-A8LF tumor 74 MALE Stage I 0 799 0 799 0 799 0 799 6.633 7.6855 TCGA-O8-A75V tumor 54 MALE Stage I 0 538 0 538 NA NA 0 538 7.5002 9.5284 TCGA-PD-A5DF tumor 58 FEMALE Stage III 1 639 1 639 NA NA 1 639 7.98 9.3651 TCGA-QA-A7B7 tumor 48 MALE Stage II 0 94 0 94 NA NA 1 88 8.2793 9.7446 TCGA-RC-A6M3 tumor 24 MALE Stage II 0 0 0 0 0 0 0 0 10.0144 9.3775 TCGA-RC-A6M4 tumor 74 FEMALE Stage III 0 22 0 22 NA NA 0 22 8.2833 8.9024 TCGA-RC-A6M5 tumor 20 FEMALE Stage IV 0 15 0 15 NA NA 0 15 6.0038 9.7396 TCGA-RC-A6M6 tumor 75 MALE Stage II 0 9 0 9 NA NA 0 9 8.3542 6.3553 TCGA-RC-A7S9 tumor 47 FEMALE Stage I 0 640 0 640 0 640 0 640 9.628 9.2439 TCGA-RC-A7SB tumor 53 MALE Stage II 0 588 0 588 0 588 0 588 7.6777 9.1945 TCGA-RC-A7SF tumor 66 MALE Stage I 0 579 0 579 1 502 1 502 7.4522 9.227 TCGA-RC-A7SH tumor 42 MALE Stage II 0 468 0 468 1 91 1 91 7.6792 10.076 TCGA-RC-A7SK tumor 59 MALE Stage I 0 472 0 472 1 312 1 312 7.6884 8.6011 TCGA-RG-A7D4 tumor 69 MALE Stage II 0 1098 0 1098 0 1098 0 1098 9.0731 10.3075 TCGA-T1-A6J8 tumor 68 MALE 0 23 0 23 NA NA 0 23 6.7867 6.8098 TCGA-UB-A7MA tumor 62 FEMALE Stage II 0 848 0 848 NA NA 1 221 7.6591 11.7112 TCGA-UB-A7MB tumor 24 MALE Stage II 0 601 0 601 1 48 1 48 9.6441 10.2055 TCGA-UB-A7MC tumor 59 MALE Stage III 0 500 0 500 1 359 1 359 9.037 10.1253 TCGA-UB-A7MD tumor 67 MALE Stage I 1 52 0 52 0 52 0 52 7.7338 8.6541 TCGA-UB-A7ME tumor 51 MALE Stage I 0 486 0 486 0 486 0 486 8.3845 9.9169 TCGA-UB-A7MF tumor 56 MALE Stage III 1 214 1 214 1 133 1 133 9.2274 9.5577 TCGA-UB-AA0U tumor 60 MALE Stage II 0 327 0 327 NA NA 1 106 9.8338 9.435 TCGA-UB-AA0V tumor 69 FEMALE Stage I 0 314 0 314 0 314 0 314 5.9646 9.9267 TCGA-WJ-A86L tumor 68 FEMALE Stage I 0 345 0 345 0 345 0 345 8.0297 6.3847 TCGA-WQ-A9G7 tumor 71 FEMALE 0 30 0 30 0 30 0 30 9.0101 10.9385 TCGA-WQ-AB4B tumor 62 MALE Stage II 0 395 0 395 1 273 1 273 7.9533 9.9589 TCGA-WX-AA44 tumor 64 FEMALE Stage I 0 615 0 615 NA NA 1 246 8.1941 8.5924 TCGA-WX-AA46 tumor 61 MALE Stage II 0 756 0 756 0 756 0 756 5.9463 9.4502 TCGA-WX-AA47 tumor 33 FEMALE Stage III 1 556 1 556 1 103 1 103 7.0997 10.4385 TCGA-XR-A8TC tumor 43 FEMALE Stage I 0 1339 0 1339 0 1339 0 1339 8.24 9.5418 TCGA-XR-A8TD tumor 49 FEMALE Stage III 0 1030 0 1030 0 1030 0 1030 8.0539 9.1326 TCGA-XR-A8TE tumor 16 MALE Stage III 0 925 0 925 1 210 1 210 6.5722 9.9867 TCGA-XR-A8TF tumor 74 MALE Stage I 1 693 0 693 1 231 1 231 8.6141 10.0037 TCGA-XR-A8TG tumor 58 MALE Stage I 0 898 0 898 1 350 1 350 8.6847 8.1179 TCGA-YA-A8S7 tumor 68 MALE Stage III 1 412 1 412 1 398 1 398 8.9913 10.0309 TCGA-ZP-A9CV tumor 59 MALE 1 1088 1 1088 NA NA 1 1088 7.3786 10.0029 TCGA-ZP-A9CY tumor 66 FEMALE 0 782 0 782 0 782 0 782 7.2688 9.67 TCGA-ZP-A9CZ tumor 72 MALE 0 706 0 706 0 706 0 706 9.8017 9.9852 TCGA-ZP-A9D0 tumor 67 FEMALE 0 1091 0 1091 0 1091 0 1091 6.313 9.6126 TCGA-ZP-A9D1 tumor 56 FEMALE 0 21 0 21 0 21 0 21 7.6694 9.9134 TCGA-ZP-A9D2 tumor 51 MALE 1 765 1 765 1 315 1 315 8.031 9.379 TCGA-ZP-A9D4 tumor 64 FEMALE 0 395 0 395 0 395 0 395 7.3913 9.8027 TCGA-ZS-A9CD tumor 73 MALE Stage II 1 1386 NA 1386 1 371 1 371 6.1318 10.4332 TCGA-ZS-A9CE tumor 79 FEMALE Stage II 0 1241 0 1241 0 1241 1 892 7.3286 8.6588 TCGA-ZS-A9CF tumor 64 MALE Stage II 0 2412 0 2412 1 636 1 636 7.3175 8.6832 TCGA-ZS-A9CF tumor 64 MALE Stage II 0 2412 0 2412 1 636 1 636 7.6078 8.4798 TCGA-ZS-A9CG tumor 55 MALE Stage II 0 341 0 341 0 341 0 341 4.6825 9.3015